Ramiro G. Peru - 05 Aug 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
Director
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
05 Aug 2024
Net transactions value
-$400,235
Form type
4
Filing time
06 Aug 2024, 17:23:28 UTC
Previous filing
21 Jun 2024
Next filing
05 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Sale $400,235 -753 -7.9% $531.52 8,744 05 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2024.